RCVRN
Recoverin
Also known as: RCV1, RECO_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35243
- Gene
- RCVRN
- Ensembl
- ENSG00000109047
- Chromosome
- 17
- Canonical length
- 200 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Mid piece,Principal piece
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the recoverin family of neuronal calcium sensors. The encoded protein contains three calcium-binding EF-hand domains and may prolong the termination of the phototransduction cascade in the retina by blocking the phosphorylation of photo-activated rhodopsin. Recoverin may be the antigen responsible for cancer-associated retinopathy. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
200 residues, UniProt reviewed canonical sequence.
>P35243|RCVRN
1 MGNSKSGALS KEILEELQLN TKFSEEELCS WYQSFLKDCP TGRITQQQFQ SIYAKFFPDT
61 DPKAYAQHVF RSFDSNLDGT LDFKEYVIAL HMTTAGKTNQ KLEWAFSLYD VDGNGTISKN
121 EVLEIVMAIF KMITPEDVKL LPDDENTPEK RAEKIWKYFG KNDDDKLTEK EFIEGTLANK
181 EILRLIQFEP QKVKEKMKNALocalizationUniProt · AlphaFold · HPA
Whether an antibody against RCVRN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 431 nTPM
Expression across tissuesHPA
Tissue
- retina: 431 nTPM
- choroid plexus: 2.1 nTPM
- cerebral cortex: 0.6 nTPM
- cerebellum: 0.3 nTPM
- amygdala: 0.2 nTPM
- basal ganglia: 0.2 nTPM
Single-cell type
- rod photoreceptor cells: 1,775 nCPM
- cone photoreceptor cells: 619 nCPM
- müller glia: 70 nCPM
- retinal bipolar cells: 29 nCPM
- retinal horizontal cells: 28 nCPM
- melanocytes: 7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 2.4 nTPM
- basal ganglia: 1.7 nTPM
- white matter: 1.5 nTPM
- hippocampal formation: 1.4 nTPM
- amygdala: 1.2 nTPM
- choroid plexus: 1.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RCVRN.
Disease | AutoantibodyPubMed
Conditions in which antibodies against RCVRN are reported. Each links to that disease's full target list.
Showing 2 of 8 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for RCVRN from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
64 publications
- Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
2004 · BMC Ophthalmol · RCR 5.3 · 178 citations - Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy.
1995 · Proc Natl Acad Sci U S A · RCR 4.7 · 173 citations - Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
1999 · Arch Ophthalmol · RCR 4 · 109 citations - Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.
1997 · Invest Ophthalmol Vis Sci · RCR 3.9 · 122 citations - Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
1993 · Invest Ophthalmol Vis Sci · RCR 3.7 · 98 citations
Show 20 more of 64 total
- Autoimmune retinopathy.
2012 · Ophthalmologica · RCR 3.2 · 74 citations - Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
1998 · Am J Ophthalmol · RCR 3.1 · 93 citations - Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy.
1993 · Invest Ophthalmol Vis Sci · RCR 3 · 85 citations - Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
1998 · J Autoimmun · RCR 2.9 · 109 citations - Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
2000 · Arch Ophthalmol · RCR 2.8 · 94 citations - Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
2003 · Autoimmun Rev · RCR 2.4 · 86 citations - Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway.
2002 · J Neuroimmunol · RCR 2.2 · 86 citations - Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
1999 · Invest Ophthalmol Vis Sci · RCR 2 · 73 citations - Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
1998 · Arch Ophthalmol · RCR 1.9 · 53 citations - A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase.
2014 · BMC Ophthalmol · RCR 1.7 · 31 citations - Neuro-ophthalmology and paraneoplastic syndromes.
2004 · Curr Opin Neurol · RCR 1.7 · 53 citations - Plasma Antiretinal Autoantibody Profiling and Diagnostic Efficacy in Patients With Autoimmune Retinopathy.
2023 · Am J Ophthalmol · RCR 1.7 · 7 citations - Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
2001 · Invest Ophthalmol Vis Sci · RCR 1.7 · 66 citations - Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy.
2016 · PLoS One · RCR 1.6 · 31 citations - Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells.
2006 · J Autoimmun · RCR 1.6 · 51 citations - Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy.
2004 · J Autoimmun · RCR 1.6 · 57 citations - Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
2004 · Lung Cancer · RCR 1.4 · 54 citations - Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
2005 · Am J Ophthalmol · RCR 1.2 · 39 citations - Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
2005 · Am J Ophthalmol · RCR 1.2 · 41 citations - Epitope recognition of recoverin in cancer associated retinopathy: evidence for calcium-dependent conformational epitopes.
1996 · J Neurosci Res · RCR 1 · 34 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- phototransduction
- regulation of calcium ion transport
- regulation of signal transduction
- signal transduction
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RCVRN as an antibody target. Whether an autoantibody or antibody against RCVRN could matter depends on whether native RCVRN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RCVRN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RCVRN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...